Quarterly Results

SUVEN LIFE SCIENCES LTD.

NSE : SUVENBSE : 530239ISIN CODE : INE495B01038Industry : Pharmaceuticals & DrugsHouse : Private
BSE111.47-1.72 (-1.52 %)
PREV CLOSE ( ) 113.19
OPEN PRICE ( ) 113.61
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 17532
TODAY'S LOW / HIGH ( )110.51 114.25
52 WK LOW / HIGH ( )55.01 128.79
NSE111.45-2.15 (-1.89 %)
PREV CLOSE( ) 113.60
OPEN PRICE ( ) 115.65
BID PRICE (QTY) 111.45 (550)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 169884
TODAY'S LOW / HIGH( ) 110.50 115.65
52 WK LOW / HIGH ( )55.15 129
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
UnAudited
Net Sales
24.51
30.6
37.97
26.11
Total Expenditure
486.43
265.7
318.11
341.32
PBIDT (Excl OI)
-461.92
-235.1
-280.14
-315.21
Other Income
60.66
51.42
56.4
56.02
Operating Profit
-401.27
-183.69
-223.74
-259.19
Interest
0.35
0.42
0.51
0.54
Exceptional Items
NA
74.57
NA
NA
PBDT
-401.62
-109.54
-224.25
-259.73
Depreciation
16.03
17.26
16.65
16.72
Profit Before Tax
-417.65
-126.8
-240.9
-276.45
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-417.65
-126.8
-240.9
-276.45
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-417.65
-126.8
-240.9
-276.45
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-417.65
-126.8
-240.9
-276.45
Equity Capital
218.07
218.07
218.07
218.07
Face Value (IN RS)
1
1
1
1
Reserves
NA
NA
NA
NA
Calculated EPS
-1.91
-0.58
-1.10
-1.26
Calculated EPS (Annualised)
-7.66
-2.32
-4.41
-5.07
No of Public Share Holdings
66368016
66368016
66368016
66368016
% of Public Share Holdings
30.43
30.43
30.43
30.43
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-1884.61
-768.30
-737.79
-1207.23
PBIDTM%
-1637.16
-600.29
-589.25
-992.68
PBDTM%
-1638.59
-357.97
-590.59
-994.75
PBTM%
-1703.99
-414.37
-634.44
-1058.78
PATM%
-1703.99
-414.37
-634.44
-1058.78
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.